and in
combination with cisplatin in a human ovarian cancer xenograft model. Cisplatin was used as a comparator
Karasev, S.M.,
Sufianov, A.A.,
Khafizov, R.R.,
Karaseva, I.I.,
Shugushev, Z.K.,
Maximkin, D.A.,
Khafizov, T.N. (2021) , and a
combination of these methods. To date, there is no pharmacotherapy available that allows you
Gareeva, A.E.,
Sharafiev, R.R.,
Akhmetova, E.A.,
Nasibullin, T.R.,
Fakhurtdinova, Z.R.,
Yuldashev, V.L.,
Asadullin, A.R. (2020) cannabinoids taking account of the
combined influences of genetic predisposition and attention deficit hypera
TCTAP C-187 CHALLENGING ANATOMY CAROTID ARTERY ANGIOPLASTY
COMBINED FEMORAL - RADIAL ROUTE (CFRR)